NEW YORK, May 7- Goldman Sachs Group Inc must face fraud claims brought by CIFG Assurance North America. The New York State Supreme Court's Appellate Division, First Department, reversed on Tuesday, finding that CIFG had done enough by having an outside consultant analyze the loans.
**RADCOM LTD, $4.05, up 53 pct. **DELCATH SYSTEMS INC, $0.43, down 45 pct. **LINKEDIN CORP, $181.69, down 10 pct.
**RADCOM LTD, $4.05, up 53 pct. **DELCATH SYSTEMS INC, $0.43, down 45 pct. **LINKEDIN CORP, $181.69, down 10 pct.
**RADCOM LTD, $4.05, up 53 pct. **DELCATH SYSTEMS INC, $0.43, down 45 pct. **LINKEDIN CORP, $181.69, down 10 pct.
**LINKEDIN CORP, $186.46, down 8 pct. **VIVUS INC, $13.28, up 3 pct. Arena said on Thursday that it pulled its application seeking approval for its anti-obesity treatment Belviq in the European Union, lowering competition for rival Vivus, whose obesity pill was recommended for European approval by regulators late last month.
May 3-:* Zions Bancorporation: Guggengeim raises target price to $28 from $26; rating neutral. rating buy* Suntrust Banks Inc: Guggengeim raises target price to $33.50 from $32.50; rating neutral* Regions Financial Corp: Guggengeim raises target price to $10 from $9.50; rating buy.
**RADCOM LTD, $4.05, up 53 pct. **LINKEDIN CORP, $181.69, down 10 pct. The U.S. Justice Department is suing the company and its hospice subsidiaries, including the biggest U.S. for-profit hospice chain, alleging false billings for Medicare hospice services.
*Zions Bancorporation: Guggenheim raises target price to $28 from $26; rating neutral. *Wells Fargo& Co: Guggenheim raises target price to $47 from $46.50; rating buy. *Citigroup Inc: Guggenheim raises price target to $58 from $57; rating buy.